&Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Sell
18,554
-3,874
-17% -$305K 0.01% 1148
2025
Q4
$1.85M Buy
22,428
+6,897
+44% +$537K 0.01% 908
2025
Q3
$1.16M Buy
15,531
+2,010
+15% +$150K 0.01% 1016
2025
Q2
$1M Sell
13,521
-1,098
-8% -$76.4K 0.01% 973
2025
Q1
$1.17M Buy
14,619
+6,924
+90% +$595K 0.01% 761
2024
Q4
$619K Buy
7,695
+2,029
+36% +$172K 0.01% 977
2024
Q3
$532K Buy
+5,666
New +$476K 0.01% 840

Other funds holding GEHC

&Partners's GEHC Position: Q1 2026 in Review

&Partners reduced its GE HealthCare (GEHC) stake by 17% in Q1 2026, selling an estimated $305K and leaving 18,554 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #1148.

&Partners first reported a position in GEHC in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.85M in Q4 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • &Partners held 18,554 shares of GE HealthCare worth $1.32M as of Q1 2026.
  • &Partners sold 3,874 GE HealthCare shares in Q1 2026, an estimated $305K.
  • GE HealthCare made up 0.01% of &Partners's portfolio in Q1 2026, its #1148 holding.
  • &Partners first reported a position in GE HealthCare in Q3 2024 and has held it in 7 quarters since.
  • &Partners's GE HealthCare position peaked at $1.85M in Q4 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.